Proteotype Diagnostics is recruiting a Doctoral Candidate (DC14) as part of the HER-CARE Marie Skłodowska-Curie Doctoral Network, a European programme training the next generation of researchers in hereditary and early-stage breast cancer.

The project will focus on the development of circulating proteomic biomarkers for early breast cancer detection and prediction of treatment response, using Proteotype’s proprietary biomarker platform.

The doctoral candidate will:

• Investigate detection of early-stage (Stage I–III) breast cancer
• Analyse biomarker dynamics during systemic and neoadjuvant therapies
• Predict pathological complete response (pCR)
• Integrate proteomic, clinical, and epidemiological datasets
• Contribute to translational and mechanistic understanding of biomarker signals

Selected samples will also undergo advanced LC-MS proteomic analysis in collaboration with the Medical University of Vienna.